Please login to the form below

Not currently logged in
Email:
Password:

Pfizer veteran joins Dynavax board

Natale Ricciardi spent 39 years at pharma giant

Dynavax Natale RicciardiNatale Ricciardi has joined the board of Dynavax Technologies two years after retiring from Pfizer.

Ricciardi spent 39 years at Pfizer, advancing to president of the pharma giant's global manufacturing business and senior VP of its North American operations.

He was also a member of the Pfizer executive leadership team when he retired in 2011.

Dynavax, which focuses on developing products to prevent and treat infectious and inflammatory diseases, will benefit from this senior experience as it looks to bring to market its lead product candidate, the hepatitis B vaccine Heplisav.

"On behalf of Dynavax, we are delighted to welcome Nat to the board,” said Arnold Oronsky, chairman of the board at Dynavax.

“His experienced leadership, particularly in global manufacturing, will provide valuable insight to the company and we look forward to his contributions."

10th July 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics